Antibody Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| Secondary Antibody | Infusion of adipose‑derived mesenchymal stem cells inhibits skeletal muscle mitsugumin 53 elevation and thereby alleviates insulin resistance in type 2 diabetic rats | Mol Med Rep, 2018 Apr | Antibody | TA130023 |
| Secondary Antibody | Tumor suppressor candidate 3: A novel grading tool and predictor of clinical malignancy in human gliomas | Oncol Lett, 2018 Apr | Antibody | TA130031 |
| Secondary Antibody | Methyl ferulic acid exerts anti-apoptotic effects on L-02 cells via the ROS-mediated signaling pathway | Int J Oncol, 2018 Apr | Antibody | TA140003 |
| Secondary Antibody | Nicotinamide N‑methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1 | Oncol Lett, 2018 Apr | Antibody | TA130023 |
| Secondary Antibody | High expression of HAX-1 protein is associated with tumor growth in papillary thyroid carcinoma | Int J Clin Exp Pathol, 2018 Apr | Antibody | TA130003 |
| Secondary Antibody | High expression of HAX-1 protein is associated with tumor growth in papillary thyroid carcinoma | Int J Clin Exp Pathol, 2018 Apr | Antibody | TA140003 |
| Secondary Antibody | Identification of a conserved linear B-cell epitope in the Staphylococcus aureus GapC protein | Microb. Pathog., 2018 Mar | Antibody | TA130003 |
| Secondary Antibody | MicroRNA-23a-5p regulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting mitogen-activated protein kinase-13 | Mol Med Rep, 2018 Mar | Antibody | TA140003 |
| Secondary Antibody | In vitro study on reversal of ovarian cancer cell resistance to cisplatin by naringin via the nuclear factor-κB signaling pathway | Exp Ther Med, 2018 Mar | Antibody | TA130015 |
| Secondary Antibody | miR-590-3p mediates melatonin-induced cell apoptosis by targeting septin 7 in the human osteoblast cell line hFOB 1.19 | Mol Med Rep, 2018 Mar | Antibody | TA140003 |
| Secondary Antibody | Curcumol attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via TGF-β1 | Mol Med Rep, 2018 Mar | Antibody | TA130010 |
| Secondary Antibody | Curcumol attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via TGF-β1 | Mol Med Rep, 2018 Mar | Antibody | TA130020 |
| Secondary Antibody | The downregulation of Rap1 GTPase-activating protein is associated with a poor prognosis in colorectal cancer and may impact on tumor progression | Oncol Lett, 2018 Mar | Antibody | TA130003 |
| Secondary Antibody | Reduction of cross-reactive carbohydrate determinants in plant foodstuff: elucidation of clinical relevance and implications for allergy diagnosis | PLoS ONE, 2018 Mar | Antibody | SM3061F |
| Secondary Antibody | Reduction of cross-reactive carbohydrate determinants in plant foodstuff: elucidation of clinical relevance and implications for allergy diagnosis | PLoS ONE, 2018 Mar | Antibody | SM3061P |
| Secondary Antibody | Reduction of cross-reactive carbohydrate determinants in plant foodstuff: elucidation of clinical relevance and implications for allergy diagnosis | PLoS ONE, 2018 Mar | Antibody | SM3061PE |
| Secondary Antibody | miR‑203 contributes to pre‑eclampsia via inhibition of VEGFA expression | Mol Med Rep, 2018 Feb | Antibody | TA130008 |
| Secondary Antibody | MiR-134, Epigenetically Silenced in Gliomas, could Mitigate the Malignant Phenotype by Targeting KRAS | Carcinogenesis, 2018 Feb | Antibody | TA130003 |
| Secondary Antibody | MiR-134, Epigenetically Silenced in Gliomas, could Mitigate the Malignant Phenotype by Targeting KRAS | Carcinogenesis, 2018 Feb | Antibody | TA130023 |
| Secondary Antibody | Significance of low level infliximab in the absence of anti-infliximab antibodies | World J. Gastroenterol., 2018 Feb | Antibody | AM20252HR-N |
| Secondary Antibody | Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure | Exp Ther Med, 2018 Feb | Antibody | TA130015 |
| Secondary Antibody | Cholesterol of lipid rafts is a key determinant for entry and post-entry control of porcine rotavirus infection | BMC Vet. Res., 2018 Feb | Antibody | TA130021 |
| Secondary Antibody | Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection | J Nanobiotechnology, 2018 Jan | Antibody | TA130013 |
| secondary antibody | A Pectin Methylesterase Inhibitor Enhances Resistance to Verticillium Wilt | Plant Physiol., 2018 Jan | Antibody | TA130003 |
| Secondary Antibody | Nicotinamide N-methyltransferase promotes epithelial-mesenchymal transition in gastric cancer cells by activating transforming growth factor-β1 expression | Oncol Lett, 2018 Jan | Antibody | TA130004 |
| Secondary Antibody | Nicotinamide N-methyltransferase promotes epithelial-mesenchymal transition in gastric cancer cells by activating transforming growth factor-β1 expression | Oncol Lett, 2018 Jan | Antibody | TA130024 |
| Secondary Antibody | Nicotinamide N-methyltransferase promotes epithelial-mesenchymal transition in gastric cancer cells by activating transforming growth factor-β1 expression | Oncol Lett, 2018 Jan | Antibody | TA130031 |
| Secondary Antibody | High expression of PRPS1 induces an anti-apoptotic effect in B-ALL cell lines and predicts an adverse prognosis in Chinese children with B‑ALL | Oncol Lett, 2018 Jan | Antibody | TA140003 |
| Secondary Antibody | The effect of Bu Zhong Yi Qi decoction on simulated weightlessness‑induced muscle atrophy and its mechanisms | Mol Med Rep, 2017 Aug | Antibody | TA130003 |
| Secondary antibody | Monoallelic and biallelic CREB3L1 variant causes mild and severe osteogenesis imperfecta, respectively | Genet. Med., 2017 Aug | Antibody | TA130004 |
| Secondary Antibody | iTRAQ‑coupled 2D LC/MS‑MS analysis of CXCR7‑transfected papillary thyroid carcinoma cells: A new insight into CXCR7 regulation of papillary thyroid carcinoma progression and identification of potential biomarkers | Oncology Letters, 2017 Jul | Antibody | TA130015 |
| Secondary Antibody | iTRAQ‑coupled 2D LC/MS‑MS analysis of CXCR7‑transfected papillary thyroid carcinoma cells: A new insight into CXCR7 regulation of papillary thyroid carcinoma progression and identification of potential biomarkers | Oncology Letters, 2017 Jul | Antibody | TA130001 |
| Secondary Antibody | Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy | Oncology Letter, 2017 Jun | Antibody | TA130005 |
| Secondary Antibody | Tryptase expression as a prognostic marker in patients with resected gastric cancer | Br J Surg, 2017 May | Antibody | TA130002 |
| Secondary Antibody | Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution | Nature, 2017 Apr | Antibody | TA130004 |
| Secondary Antibody | Surfactant protein A is expressed in the central nervous system of rats with experimental autoimmune encephalomyelitis, and suppresses inflammation in human astrocytes and microglia | Mol Med Rep, 2017 Apr | Antibody | TA130023 |
| Secondary Antibody | Decreased expression of insulin-like growth factor binding protein 6 is associated with gastric adenocarcinoma prognosis | ONCOLOGY LETTERS, 2017 Apr | Antibody | TA130031 |
| Secondary Antibody | PRDX1 overexpression contributes to the protection on chondrocytes from IL-1β-induced apoptosis | Int J Clin Exp Med, 2017 Apr | Antibody | TA130004 |
| Secondary Antibody | Mesenchymal stem cells increase expression of heme oxygenase-1 leading to anti-inflammatory activity in treatment of acute liver failure | Stem Cell Res Ther, 2017 Mar | Antibody | TA130023 |
| Secondary Antibody | Cyclosporine A attenuates cardiac dysfunction induced by sepsis via inhibiting calcineurin and activating AMPK signaling | Mol Med Rep, 2017 Mar | Antibody | TA130002 |
| Secondary Antibody | Cyclosporine A attenuates cardiac dysfunction induced by sepsis via inhibiting calcineurin and activating AMPK signaling | Mol Med Rep, 2017 Mar | Antibody | TA140003 |
| Secondary Antibody | Mice endometrium receptivity in early pregnancy is impaired by maternal hyperinsulinemia | MOLECULAR MEDICINE REPORTS, 2017 Mar | Antibody | TA130003 |
| Secondary antibody | Characterization of VdASP F2 secretory factor from Verticillium dahliae by a fast and easy gene knockout system | Mol. Plant Microbe Interact, 2017 Mar | Antibody | TA130004 |
| Secondary Antibody | Mice endometrium receptivity in early pregnancy is impaired by maternal hyperinsulinemia | MOLECULAR MEDICINE REPORTS, 2017 Mar | Antibody | TA130023 |
| Secondary Antibody | PAR1‑mediated c‑Jun activation promotes heat stress‑induced early stage apoptosis of human umbilical vein endothelial cells | Molecular Medicine Reports, 2017 Mar | Antibody | TA130023 |
| Secondary Antibody | Blockade of CD40-CD154 costimulatory pathway promotes long-term survival of full-thickness porcine corneal grafts in nonhuman primates: clinically applicable xenocorneal transplantation | Am. J. Transplant., 2017 Feb | Antibody | AP31438FC-N |
| Secondary Antibody | Detection of human cytomegalovirus in tumor tissue and peripheral blood samples of patients with gliomas | Int J Clin Exp Pathol, 2017 Feb | Antibody | TA130010 |
| Secondary Antibody | Effects of interventional therapy with norcantharidin-loaded gelatin microspheres on hepatocellular carcinoma in mice and its mechanism | Int J Clin Exp Med, 2017 Feb | Antibody | TA140003 |
| Secondary Antibody | Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response | Hum. Immunol., 2017 Jan | Antibody | AM01158AP-N |
| Secondary Antibody | Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response | Hum. Immunol., 2017 Jan | Antibody | AM01158HR-N |
Germany
Japan
United Kingdom
China